Advertisement

Related Videos

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Deborah Collyar: What's In It for Patients?

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Varsha Gandhi, PhD, on Ibrutinib

Advertisement

Advertisement




Feb
26
Today In Oncology
Long-Term Health Risks for Testicular Cancer Survivors Differ by Chemotherapy Regimen
Cancer Diagnoses During COVID-19 Pandemic: Impact on 1-Year Cause-Specific Survival
‘Prostate Screening Saved My Life’—Is That Really True In Most Cases?
Effect of Medicaid Expansion on Diagnosis, Treatment, and Outcomes in NSCLC
How the Outlook on Fertility Preservation for Patients With Cancer Is Improving
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo